With more than 75 years in the trade, Actylis sources and manufactures critical ingredients and raw materials for pharmaceutical, biopharmaceutical, nutrition and specialty-chemical makers. Its global network combines in-house production with tailored sourcing, process development and supply-chain support, including a 30,000-square-foot cGMP API facility in Eugene and Water for Injection capabilities in Montreal. Actylis operates ISO 9001:2015-certified facilities and supports customers from early development through commercial-scale production.
ISO 9001:2015
certification
GMP
certification
GDP
certification
EXCiPACT
certification
Health Canada Drug Establishment Licence
registration
FDA and Health Canada Audited
compliance_program
ISO 14644-1 Class 7 Clean Environment
compliance_program
ActylisActylis supplies and manufactures specialty ingredients and raw materials for products ranging from pharmaceuticals and nutraceuticals to cosmetics and industrial formulations. Its portfolio spans everyday formulation inputs such as plant-origin Inositol NF and L-Cysteine alongside more distinctive offerings, including Citroleo’s natural Brazilian Candeia-derived α-Bisabolol and Emissary’s encapsulated cosmetic delivery systems. The company’s materials are supported by decades of sourcing and manufacturing experience, with products available across 438 listings and 13 brands.PORT WASHINGTON, NY
Gyma Laboratories of America, IncEstablished in 1951, Gyma Laboratories of America connects pharmaceutical companies with the active ingredients, development partners, and regulatory support needed to move drugs from research toward market. The company has supplied APIs to the U.S. pharmaceutical industry for more than 70 years and now operates across North America, Europe, and Asia, with newer capabilities in biotechnology and mRNA development. Its work spans the drug life cycle, including support for more than 1,000 first-to-market APIs under ANDA filings since 1971.WOODBURY, NY
Curia Global, IncFounded in Albany in 1991 as Albany Molecular Research, Curia is a global contract research, development and manufacturing organization serving pharmaceutical and biotechnology companies from drug discovery through commercial production. The company now operates an integrated network of more than 20 facilities across North America, Europe and India, with more than 3,000 professionals supporting small-molecule and biologics programs. Curia’s history includes discovery and development of the active pharmaceutical ingredient in Allegra and deep experience scaling complex APIs, sterile drug products and biologics.ALBANY, NY
Par HealthPar Health makes essential medicines, including active pharmaceutical ingredients, generic drugs and sterile injectables, through a global manufacturing network. Formed from the merger of Mallinckrodt and Endo, the company carries more than 160 years of pharmaceutical experience, including a St. Louis API site with roots reaching back over 160 years. With 10 manufacturing facilities, two R&D centers and products reaching more than 70 countries, Par Health combines that long industrial history with a broad modern supply network.HOBART, NY